Vertiseit (Q3 Initial take): Organic ARR acceleration – Cash EBITDA ahead of expectations - Redeye
Bildkälla: Stockfoto

Vertiseit (Q3 Initial take): Organic ARR acceleration – Cash EBITDA ahead of expectations - Redeye

Redeye comments on Vertiseit's Q3 report, showing ARR ahead of our forecast with accelerating organic growth, and an adjusted EBITDA-CAPEX (Cash EBITDA) above our expectations. Cash flow was held back by temporary Scala-related effects. Overall, a solid report, where Vertiseit beats our expectations slightly on all key numbers. We will likely raise our forecasts and underlying Base Case somewhat, although raising the risk-free rate from 2.5% to 3.0% in our WACC might mitigate that effect.

Redeye comments on Vertiseit's Q3 report, showing ARR ahead of our forecast with accelerating organic growth, and an adjusted EBITDA-CAPEX (Cash EBITDA) above our expectations. Cash flow was held back by temporary Scala-related effects. Overall, a solid report, where Vertiseit beats our expectations slightly on all key numbers. We will likely raise our forecasts and underlying Base Case somewhat, although raising the risk-free rate from 2.5% to 3.0% in our WACC might mitigate that effect.
Börsvärldens nyhetsbrev